Chemical Structure (Amidate 01)
Not available.*
Amidate Injection, Solution
Product Images NDC 0409-6695
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amidate (NDC 0409-6695). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Amidate 02)
Principal Display Panel (10 mL Vial Label)
This is a description of a drug called Etomidate Injection, USP that comes in a 0 mL single-dose Fliptop vial. Each mL contains 2mg of etomidate and propyleneglycol 35% v/v. It is sterile and monpyrogenic and should only be used intravenously. The product is distributed by Hospira, Inc., based in Lake Forest, IL, USA. There is also a usual dosage that should be referred to before use. The rest of the text is unclear or non-English characters.*
Principal Display Panel (10 mL Vial Tray)
Principal Display Panel (20 mL Vial Label)
This is a medication for intravenous use only, called Etomidate Injection, which comes in a single-dose Fliptop vial. The NDC code is 0409-6695-12 and it is distributed by Hospira, Inc. Each mL of the injection contains 2 mg of etomidate and propylene glycol. The dosage instructions are included in the insert and any unused portion must be discarded. The text also includes a code, which might be a product code, RL-7186.*
Principal Display Panel (20 mL Vial Tray)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
